Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1Myeloid 1Gynecologic 1

Conditions

Osteoporosis 5Breast Neoplasms 5Colorectal Neoplasms 3Vitamin D Deficiency 2Thyroid Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms 2Lymphoma 2Leukemia 2Thyroiditis 1Prostatic Neoplasms 1Polyps 1Polycystic Ovary Syndrome 1Pain 1Ovarian Neoplasms 1Obesity 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Hypocalcemia 1Hyperthyroidism 1Goiter 1Colonic Polyps 1Colonic Neoplasms 1Bone Diseases, Metabolic 1Arthralgia 1Aflatoxin Poisoning 1Adenomatous Polyps 1Adenoma 1

Interventions

Cyclophosphamide 282Rituximab 260Etoposide 161Filgrastim 155Vincristine 145Doxorubicin 134Prednisone 117Cytarabine 108Radiotherapy 102Peripheral Blood Stem Cell Transplantation 90Methotrexate 90fludarabine phosphate 87Melphalan 78Busulfan 71Dexamethasone 59Granulocyte Colony-Stimulating Factor 56Carmustine 53fludarabine 51Bortezomib 46Tacrolimus 44Mycophenolic Acid 41Antilymphocyte Serum 41Ifosfamide 40Leucovorin 39Gemcitabine 38Whole-Body Irradiation 36Cyclosporine 35Bendamustine Hydrochloride 34sargramostim 33Methylprednisolone 32

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Lymphoma × Calcium Carbonate × Clear all
NCT00321932 2017-03-09

Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant

University of Minnesota

Phase 2 Completed
61 enrolled 16 charts
GynecologicLymphoidMyeloidOther hematologic neoplasm

Leukemia, Lymphoma, Myelodysplastic Syndromes, Osteoporosis, Ovarian Neoplasms

NCT00352846 2013-07-02

Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss

M.D. Anderson Cancer Center

Phase 3 Completed
135 enrolled 4 charts
Lymphoid

Bone Diseases, Metabolic, Lymphoma, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡